Fulgent Genetics agrees to buy StrataDx and assets from Bako Diagnostics for $55.5 million. Learn how this cash deal expands ...

ACLU and PUBPAT Argue Against Patents on Breast Cancer Genes in Appeals Court ACLU and PUBPAT Argue Against Patents on Breast Cancer Genes in Appeals Court ...

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites ...

Baculoviruses are a diverse family of large, circular double‐stranded DNA viruses that infect insect larvae and play a pivotal role in natural microbial control. Advances in genomic technologies have ...

Myriad Genetics and Lumea Inc. partner to integrate molecular diagnostics into Lumea's digital pathology platform, enhancing cancer care efficiency. Myriad Genetics and Lumea Inc. have announced a ...

CEO Ming Hsieh highlighted year-over-year growth in the laboratory services segment and momentum in 2025. The company's therapeutic development pipeline progresses with FID-007 in Phase 2 trials for ...

FLGT currently has a market capitalization of $853.49 million.

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS' ...

Who Should Control Your Genetic Information — You or Corporate Laboratories? Who Should Control Your Genetic Information — You or Corporate Laboratories? VICTORY! Supreme Court Decides: Our Genes ...